Insights Into Myelofibrosis (MF)

Perspectives on drivers in treatment decisions in the management of myelofibrosis (MF)

Gulf #1 – January 12, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX, USA

Midwest #1 – January 18, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio, TX, USA

Northeast #1 – January 19, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Midwest #2 – January 25, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio, TX, USA

Northeast #2 – January 26, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Northeast #3 – February 2, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Ohio Valley – February 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital, Ann Arbor, MI, USA

West #2 – February 16, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center, Houston, TX, USA

West #3 – February 23, 2022

Faculty Chair

Srdan Verstovsek, MD, PhD

MD Anderson Cancer Center, Houston, TX, USA

Ohio Valley #2 – March 9, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital, Ann Arbor, MI, USA

Midwest #3 – March 15, 2022

Faculty Chair

Ruben Mesa, MD

UT Health San Antonio, TX, USA

Ohio Valley #3 – March 30, 2022

Faculty Chair

Kristen Pettit, MD

C.S. Mott Children's Hospital, Ann Arbor, MI, USA

Gulf #2 – April 6, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX, USA

Southeast #1 – April 7, 2022

Faculty Chair

Elias Jabbour, MD

MD Anderson Cancer Center, Houston, TX, USA

Gulf #3 – April 13, 2022

Faculty Chair

Prithviraj Bose, MD

MD Anderson Cancer Center, Houston, TX, USA

Mid-Atlantic #1 – April 20, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Southeast #2 – April 27, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Mid-Atlantic #3 – May 3, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Mid-Atlantic #2 – May 4, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Southeast #3 – May 18, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Florida Cancer Specialists – September 13, 2022

Faculty Chair

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL, USA

Tennessee Oncology – September 22, 2022

Faculty Chair

Jonathan Abbas, MD

Tennessee Oncology

University of Alabama – October 10, 2022

Faculty Chair

Pankit Vachhani, MD

University of Alabama

New York Cancer & Blood Specialists – October 12, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Zangmeister – November 1, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

TOPA – November 16, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

OneOnc – November 28, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Maryland Oncology – December 1, 2022

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

RCCA – December 5, 2022

Faculty Chair

John Mascarenhas, MD

The Mount Sinai Hospital, New York, NY, USA

Henry Ford & Karmanos-Detroit – December 6, 2022

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

Norton Healthcare-Louisville – December 15, 2022

Faculty Chair

Rami Komrokji, MD

Moffitt Cancer Center, Tampa, FL, USA

Northeast Academic Centers – December 15, 2022

Faculty Chair

Raajit Rampal, MD

Memorial Sloan Kettering Cancer Center, New York, NY, USA

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Northeast region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • West region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Midwest region

More Information

  • Virtual series
  • Ohio Valley region

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Southeast

More Information

  • Virtual series
  • Gulf region

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Southeast

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Mid-Atlantic region

More Information

  • Virtual series
  • Southeast

More Information

  • Virtual series
  • Florida Cancer Specialists

More Information

  • Virtual series
  • Tennessee Oncology

More Information

  • Virtual series
  • University of Alabama

More Information

  • Virtual series
  • New York Cancer & Blood Specialists

More Information

  • Virtual series
  • Zangmeister

More Information

  • Virtual series
  • TOPA

More Information

  • Virtual series
  • OneOnc

More Information

  • Virtual series
  • Maryland Oncology

More Information

  • Virtual series
  • RCCA

More Information

  • Virtual series
  • Henry Ford & Karmanos-Detroit

More Information

  • Virtual series
  • Norton Healthcare-Louisville

More Information

  • Virtual series
  • Northeast Academic Centers

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • A virtual, moderated roundtable discussion focusing on the treatment of MF
  • Disease state and data presentations are developed in conjunction with a national or regional oncology expert
  • Insights on the following therapies will be obtained
    • Current management and emerging challenges in MF
    • Current therapy paradigms for MF
    • Unmet needs and emerging paradigms

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.